Table of Contents
Efficacy Results from Three Pivotal Efficacy Trials
Pivotal European Efficacy Studies - Objective
Pivotal European Efficacy Studies
Pivotal European Efficacy Studies: Study Design Features - General
Pivotal European Study Design Features Entrance Criteria
Methods for Collecting Drinking Data in Pivotal European Efficacy Studies
Patient Disposition Pivotal European Efficacy Studies
Reasons for Discontinuation Pivotal European Efficacy Studies
Pivotal European Efficacy Studies: Demographic and Baseline Characteristics
Pivotal European Efficacy Studies Mean (S.E.) Study Drug Exposure in Weeks
Pivotal European Efficacy Studies Mean Percent Medication Compliance
Pivotal European Efficacy Studies Definitions of Common Outcome Parameters
Survival Estimate of Time to First Drink* - Pelc II
Survival Estimate of Time to First Drink* - PRAMA
Survival Estimate of Time to First Drink* - Paille
European Pivotal Efficacy Studies Rate of Complete Abstinence
European Pivotal Efficacy Studies Median Percentage of Abstinent Days on Study (CAD%)
European Pivotal Efficacy Studies Primary Efficacy Variables - Summary
ISBRA 15th–18th September 2004 Heidelberg, Germany
|